Regulatory Affairs Management for Cell and Gene Therapy Market
完整報告名稱與涵蓋範圍
Regulatory Affairs Management for Cell and Gene Therapy Market, Share & Trends Analysis Report, By Service Type (In-house Regulatory Affairs, Outsourced Regulatory Affairs), By Application (Oncology, Rare Diseases, Genetic Disorders, Other Applications), By Therapy Type, By Region, and Segment Forecasts, 2025-2034
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Regulatory Affairs Management for Cell and Gene Therapy Market is projected to register a CAGR of 14.2%.
Regulatory Affairs Management for Cell and Gene Therapy encompasses overseeing the development, submission, and compliance of regulatory documentation to ensure that cgt products meet the safety, e. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Regulatory Affairs Management for Cell and Gene Therapy Market Snapshot
Chapter 4. Global Regulatory Affairs Management for Cell and Gene Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Regulatory Affairs Management for Cell and Gene Therapy Market Industry Trends
4.10. Global Regulatory Affairs Management for Cell and Gene Therapy Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 1: By Service Type, Estimates & Trend Analysis
5.1. Market Share by Service Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type:
5.2.1. In-house Regulatory Affairs
5.2.1.1. Regulatory Strategy Development
5.2.1.2. Clinical Trial Oversight
5.2.1.3. Post-Market Compliance
5.2.1.4. Policy Engagement
5.2.1.5. Others
5.2.2. Outsourced Regulatory Affairs
5.2.2.1. CMC Regulatory Affairs
5.2.2.2. Regulatory Consulting
5.2.2.3. Process Development Compliance
5.2.2.4. Specialized Submissions
5.2.2.5. Others
Chapter 6. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Oncology
6.2.2. Rare Diseases
6.2.3. Genetic Disorders
6.2.4. Other Applications
Chapter 7. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 3: By Therapy Type, Estimates & Trend Analysis
7.1. Market Share by Therapy Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapy Type:
7.2.1. Cell Therapy
7.2.2. Gene Therapy
7.2.3. Gene-Modified Cell Therapy
Chapter 8. Regulatory Affairs Management for Cell and Gene Therapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Regulatory Affairs Management for Cell and Gene Therapy Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
8.2.3. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034
8.3. Europe
8.3.1. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
8.3.3. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
8.4.3. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034
8.5. Latin America
8.5.1. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
8.5.3. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
8.6.3. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Regulatory Affairs Management for Cell and Gene Therapy Market Revenue (US$ Million) Estimates and Forecasts by Therapy Type, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Novartis AG
9.2.1.1. Business Overview
9.2.1.2. Key Service Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Amgen Inc.
9.2.3. Pfizer Inc.
9.2.4. Biogen Inc.
9.2.5. Gilead Sciences Inc.
9.2.6. Roche
9.2.7. Johnson & Johnson
9.2.8. Sanofi
9.2.9. Bayer AG
9.2.10. AstraZeneca PLC
9.2.11. Lonza Group Ltd.
9.2.12. Catalent, Inc.
9.2.13. Thermo Fisher Scientific Inc.
9.2.14. Charles River Laboratories International, Inc.
9.2.15. WuXi AppTec
9.2.16. IQVIA Holdings Inc.
9.2.17. Parexel International Corporation
9.2.18. Syneos Health, Inc.
9.2.19. PPD, Inc.
9.2.20. CMIC Group
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們